Filter Results:
(1,020)
Show Results For
- All HBS Web
(4,477)
- Faculty Publications (1,020)
Show Results For
- All HBS Web
(4,477)
- Faculty Publications (1,020)
- 2009
- Book
Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure
A best seller in its category, with many printings. It has been recognized by the U.S. Chamber of Commerce as one of the books that made a difference in public policy in 2008. View Details
Herzlinger, Regina. Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure. McGraw-Hill, 2009.
- March 14, 2007
- Other Article
How Physicians Can Change the Future of Health Care
By: Michael E. Porter and Elizabeth Olmsted Teisberg
Keywords: Health
Porter, Michael E., and Elizabeth Olmsted Teisberg. "How Physicians Can Change the Future of Health Care." JAMA, the Journal of the American Medical Association 297, no. 10 (March 14, 2007): 1103–1111.
- 25 Jan 2007
- Other Presentation
Winning Competitive Strategies in Today's Shifting Global Marketplace
The following portion of this presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006. Earlier publications about health care include the... View Details
Porter, Michael E. "Winning Competitive Strategies in Today's Shifting Global Marketplace." Nyenrode Business Universiteit, Amsterdam, The Netherlands, January 25, 2007.
- January 2007 (Revised December 2007)
- Case
PSI: Social Marketing Clean Water
By: V. Kasturi Rangan, Nava Ashraf and Marie Bell
Senior management at PSI, arguably the world's largest and most successful social marketer with impressive achievements in the field of family planning, HIV/AIDS, and malaria prevention must determine what to do about their slow-to-take-off clean water initiative.... View Details
Keywords: Investment Funds; Health Care and Treatment; Social Marketing; Natural Environment; Social Enterprise; Business Strategy
Rangan, V. Kasturi, Nava Ashraf, and Marie Bell. "PSI: Social Marketing Clean Water." Harvard Business School Case 507-052, January 2007. (Revised December 2007.) (Request a courtesy copy.)
- November 2006
- Article
Making It Safe: The Effects of Leader Inclusiveness and Professional Status on Psychological Safety and Improvement Efforts in Health Care Teams
By: Ingrid Marie Nembhard and A. Edmondson
Nembhard, Ingrid Marie, and A. Edmondson. "Making It Safe: The Effects of Leader Inclusiveness and Professional Status on Psychological Safety and Improvement Efforts in Health Care Teams." Special Issue on Healthcare: The problems are organizational not clinical. Journal of Organizational Behavior 27, no. 7 (November 2006): 941–966. (Award for Best Paper in Positive Organizational Scholarship, Ross School of Business, University of Maryland.)
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
- September 2006 (Revised December 2006)
- Case
Arizona Department of Public Health: The Challenges of Preparing for a Public Health Emergency
By: Lynda M. Applegate, Ajay Vinze, T. S. Raghu and Minu Ipe
In the post-9/11 era information technology enablement for emergency preparedness and response have taken on increased significance. Public health organizations like ADHS play a critical role in any statewide preparation for large scale emergencies. With issues like... View Details
Keywords: Problems and Challenges; Information Technology; Health Care and Treatment; Business Processes; Service Delivery; National Security; Health Industry; Health Industry; Arizona
Applegate, Lynda M., Ajay Vinze, T. S. Raghu, and Minu Ipe. "Arizona Department of Public Health: The Challenges of Preparing for a Public Health Emergency." Harvard Business School Case 807-016, September 2006. (Revised December 2006.)
- August 2006 (Revised August 2012)
- Background Note
Connectivity in Health Care
By: Regina E. Herzlinger and Alfred Martin
This note describes the current state of information technology connectivity in the health care sector. View Details
Keywords: Health Care and Treatment; Business and Government Relations; Health Industry; Health Industry
Herzlinger, Regina E., and Alfred Martin. "Connectivity in Health Care." Harvard Business School Background Note 307-047, August 2006. (Revised August 2012.)
- July 2006 (Revised August 2012)
- Background Note
Innovating in Health Care-Glossary
Provides a glossary of terms used in Harvard Business School's Innovating in Health Care, 2006, Course. View Details
Herzlinger, Regina E. "Innovating in Health Care-Glossary." Harvard Business School Background Note 307-011, July 2006. (Revised August 2012.)
- July 2006
- Article
The Effects of Cardiac Specialty Hospitals on the Cost and Quality of Medical Care
By: Jason R. Barro, Robert S. Huckman and Daniel P. Kessler
Barro, Jason R., Robert S. Huckman, and Daniel P. Kessler. "The Effects of Cardiac Specialty Hospitals on the Cost and Quality of Medical Care." Journal of Health Economics 25, no. 4 (July 2006): 702–721.
- April 2006
- Article
The Firm Specificity of Individual Performance: Evidence from Cardiac Surgery
By: Robert S. Huckman and Gary P. Pisano
Huckman, Robert S., and Gary P. Pisano. "The Firm Specificity of Individual Performance: Evidence from Cardiac Surgery." Management Science 52, no. 4 (April 2006): 473–488.
- February 2006 (Revised February 2009)
- Case
AIDS in Brazil
By: Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details
Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)
- January 2006 (Revised April 2007)
- Case
General Electric Healthcare, 2006
By: Tarun Khanna and Elizabeth Raabe
In January 2006, Joe Hogan, head of General Electric (GE) Healthcare Technologies, prepared to step into William Castell's shoes as CEO of GE Healthcare, the world's leading manufacturer of diagnostic imaging equipment. In 2004, former CEO Jeff Immelt acquired Amersham... View Details
Keywords: Corporate Entrepreneurship; Cost vs Benefits; Growth and Development Strategy; Mergers and Acquisitions; Machinery and Machining; Global Range; Multinational Firms and Management; Product Design; Technological Innovation; Expansion; Value Creation; Business Subsidiaries; Health Industry; Health Industry
Khanna, Tarun, and Elizabeth Raabe. "General Electric Healthcare, 2006." Harvard Business School Case 706-478, January 2006. (Revised April 2007.)
- 2006
- Chapter
Consumer-Driven Healthcare: Transforming the Delivery of Health Services
By: R. E. Herzlinger
Herzlinger, R. E. "Consumer-Driven Healthcare: Transforming the Delivery of Health Services." In Futurescan: Healthcare Trends and Implications, 2006 2011, 13–20. Health Administration Press, 2006.
- 2006
- Case
In Reach Care of the Elderly: Moss Valley Medical Practice
By: Julie Battilana, A. M. Cagna and T. D'Aunno
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- November 2005 (Revised December 2005)
- Case
County Department of Public Health: Organizing for Emergency Preparedness and Response
By: Lynda M. Applegate, Ajay Vinze and Minu Ipe
The anthrax attacks of 2001 exposed serious inadequacies in the response of the U.S. public health system to meet such grave threats. The public health infrastructure required rebuilding to respond to any type of large-scale health emergency. The Public Health... View Details
Keywords: Information Technology; Change Management; Crisis Management; Health Care and Treatment; Infrastructure; Health Industry; Health Industry; United States
Applegate, Lynda M., Ajay Vinze, and Minu Ipe. "County Department of Public Health: Organizing for Emergency Preparedness and Response." Harvard Business School Case 806-089, November 2005. (Revised December 2005.)
- November 2005 (Revised November 2005)
- Case
Massachusetts General Hospital and the Enbrel Royalty
By: David S. Scharfstein and Darren R. Smart
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details
Keywords: Valuation; Price; Investment Return; Capital; Value; Revenue; Health Care and Treatment; Health Industry; Health Industry; Massachusetts
Scharfstein, David S., and Darren R. Smart. "Massachusetts General Hospital and the Enbrel Royalty." Harvard Business School Case 206-075, November 2005. (Revised November 2005.)
- November 2005 (Revised November 2011)
- Background Note
Entrepreneurship and Venture Capital in Healthcare Fall Term 2011: Course Outline and Syllabus
By: Richard G. Hamermesh and Robert F. Higgins
Provides an overview of the second-year MBA elective course Entrepreneurship and Venture Capital in Healthcare. View Details
Hamermesh, Richard G., and Robert F. Higgins. "Entrepreneurship and Venture Capital in Healthcare Fall Term 2011: Course Outline and Syllabus." Harvard Business School Background Note 806-048, November 2005. (Revised November 2011.)